Inspiring supply chain innovation for international development

  • Streamline stock velocity
  • Initiate resource mobilization
  • Manage production scheduling
  • Reduce stockouts and expiries
  • Best value and best quality products
  • Savings through pooled procurement
  • International best practices
  • Navigate regulatory environment
  • On-time and in-full deliveries
  • Cost-effective transport
  • Custom and waiver clearance
  • Safe, reliable shipments
  • Modular pharma-compliant storage
  • Fast, affordable remote installations
  • Improved in-country infrastructure
  • Professional, durable construction
  • Tailored, accurate, real-time information
  • End-to-end visibility and tracking
  • Data-driven decisions
  • Improved chain of custody
  • Safe, effective, fit-for-use products
  • Prequalification of vendors
  • ISO 9001:2015 QMS certification
  • Sampling and quality testing system

PFSCM strengthens public health supply chains, ensuring lifesaving commodities are accessible and available to communities in hard-to-reach places. We help donors, governments, non-profit organizations, and humanitarian agencies achieve their public health goals through cost-saving procurement, efficient logistics, pharmaceutical-grade storage, and real-time data tracking. PFSCM demonstrates its commitment to customer satisfaction and service excellence through our ISO 9001:2015 certified Quality Management System, which underpins all of our processes, systems, and services.

By The Numbers

In 2017

84%

of deliveries of products to fight HIV and malaria were made on time and in full (OTIF)

More Than

$5.55 billion

in lifesaving commodities delivered to 101 countries since 2005

Only

0.02%

commodity losses thanks to our rigorous security and quality assurance measures

More Than

$175 million

saved for clients through shipment planning to maximize ocean and road freight and minimize air freight

Follow @PFSCM

Encouraging results: R&D pipelines have grown markedly, due to an effective recipe for engaging pharmaceutical companies in specific R&D challenges. The R&D pipeline has more than doubled since 2014 for a set of 47 high-burden and priority diseases, including HIV/AIDS, malaria&TB

Discussions at #FTFutureHealth echoing some of the issues raised in the @WHO’s guideline on digital health interventions. From the guideline: "People must be assured that their own data is safe and that they are not being put at risk..."
https://t.co/aVmUaRGytz

All content ©2018 Partnership for Supply Chain Management, Inc. All rights reserved.